Mandate

Lendify has secured new financing of up to SEK 1,500,000,000 from, amongst others, Insight Investment

June 11, 2019 Banking and Finance

Together with, amongst others, the management of the company, the arranger and legal advisors to the arranger, Vinge has acted for Lendify in the structuring, documenting and execution of the transaction where one of the world’s largest and most well established asset managers, Insight Investment, acted as main investor.

The transaction is one of the first in Sweden to be executed and reported under the new EU securitisation regulation (Regulation (EU) 2017/2402 of the European Parliament and of the Council of 12 December 2017) and to be subject to the new reporting requirements thereunder.

Lendify has, with Vinge’s assistance, secured financing of approximately SEK 2,800,000,000 during the spring of 2019, primarily by completion of the above mentioned transaction, by completion of the transaction with a large Swedish institution previously announced in February and by establishing a credit facility with Nordea.

Vinge’s team mainly consisted of partner Albert Wållgren, associates Lionardo Ojeda and Axel Jansson (Banking and Finance) and partner Emma Stuart Beck and associate Caroline Krassén (Financial Services).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025